Continued Access to Investigational Products: Guiding Equitable and Fair Decisions - The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

Webinar

Please join us on Friday, September 12 from 11 AM – 12 PM ET for a webinar to discuss the MRCT Center’s ongoing work related to the challenges of post-trial continued access to investigational products. Post-trial continued access is a shared responsibility and should be determined before the trial begins. Even with the best planning, complex situations can arise that require research sponsors to balance various tradeoffs and impacts on stakeholders. The MRCT Center’s Post-Trial Continued Access Task Force has developed resources to guide equitable and fair decision-making related to the continued provision of the investigational medicine, or continued maintenance of the investigational significant risk device after the trial.

This webinar will introduce a series of resources, including principles, frameworks, and recommendations. Case studies will also be presented to illustrate unique complexities that sponsors and investigators must consider.

---

---